San Francisco · CA, USA · founded 2012 · http://virool.com
Diligence memoA one-page analyst read on Virool — recommendation, valuation, rhythm, risks.→Virool: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Virool provides native video advertising experience for the biggest…
A LITTLE ABOUT VIROOL Virool is a video distribution platform for brand marketers that leverages programmatic technology to reach key influencers, making content more engaging and the ability to share easier than ever. Having served more than 75,000 global campaigns, Virool’s robust ActivView product suite and in-article native unit, deliver fully transparent and insightful analytics that offers viewability guarantees, emotional resonance and fraud protection. Within our platform, users can leverage a proprietary DMP of 450MM unique profiles to build custom, addressable audience segments across all screens. More than 100,000 multi-channel sites have activated video content from Virool via partnerships including Rubicon Project and direct native placements. Founded in 2012, Virool has raised $18.62M in funding from a collection of top VC firms and angel investors, including $6.62M in its seed round. It is the biggest seed investment that anymore Y-Combinator graduate has ever received.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
No staged rounds to sequence.
Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 8525 companies in this sector. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 96% of sector peers (real $). Modeled value above 96% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| No rounds recorded. | |||||
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Virool is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Vidyard Video for business. | — | — | — | 75% |
| Virocell Biologics Ltd | Biotechnology | Pre-Seed | $12.9M | 73% |
| Vivera Pharmaceuticals, Inc. | Pharmaceuticals | Seed | $40.1M | 71% |
| Viro Media, Inc. | Media & Content | Seed | $41.8M | 70% |
| Vira Regen Inc. | Biotechnology | Seed | $5.6M | 69% |
| Imgix The platform for your visual media. | SaaS / Software | — | — | 69% |
| Trendpop Discover trends as they happen | Ecommerce / Retail | — | — | 69% |
| Viddy A new way to create landing pages that is video-native. | SaaS / Software | — | — | 69% |
See where Virool sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Virool, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.